Perrigo (PRGO) Receivables - Net (2013 - 2026)
Perrigo (PRGO) reported Receivables - Net of $697.1 million for Q1 2026, down 2.75% year-over-year from $716.8 million in Q1 2025, and up 13.76% quarter-over-quarter from $612.8 million in Q4 2025.
Perrigo (PRGO) Receivables - Net (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Receivables - Net data on file, last reported at $697.1 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $697.1 million, down 2.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $697.1 million (down 2.75% YoY), and the FY2025 annual result was $612.8 million, down 4.59% from the prior year.
- Receivables - Net rose to $697.1 million in Q1 2026 per PRGO's latest filing, from $612.8 million in the prior quarter.
- Over five years, Receivables - Net peaked at $785.9 million in Q3 2024 and troughed at $612.8 million in Q4 2025.
- A 5-year average of $711.1 million and a median of $716.8 million in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2025: Receivables - Net increased 20.98% in 2022, then declined 18.0% in 2025.
- A 5-year view of Receivables - Net shows it stood at $697.1 million in 2022, then increased by 6.1% to $739.6 million in 2023, then dropped by 13.16% to $642.3 million in 2024, then retreated by 4.59% to $612.8 million in 2025, then rose by 13.76% to $697.1 million in 2026.
- Business Quant data shows PRGO's Receivables - Net at $697.1 million in Q1 2026, $612.8 million in Q4 2025, and $644.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 697.10 Mn |
| Mar 28, 2026 | 697.10 Mn |
| Dec 31, 2025 | 612.80 Mn |
| Dec 31, 2025 | 612.80 Mn |
| Sep 27, 2025 | 644.40 Mn |
| Sep 27, 2025 | 644.40 Mn |
| Jun 28, 2025 | 678.20 Mn |
| Jun 28, 2025 | 678.20 Mn |
| Mar 29, 2025 | 716.80 Mn |
| Mar 29, 2025 | 716.80 Mn |
| Dec 31, 2024 | 642.30 Mn |
| Dec 31, 2024 | 642.30 Mn |
| Sep 28, 2024 | 785.90 Mn |
| Sep 28, 2024 | 785.90 Mn |
| Jun 29, 2024 | 726.00 Mn |
| Jun 29, 2024 | 726.00 Mn |
| Mar 30, 2024 | 780.00 Mn |
| Mar 30, 2024 | 780.00 Mn |
| Dec 31, 2023 | 739.60 Mn |
| Dec 31, 2023 | 739.60 Mn |